Intravitreal triamcinolone injection for diffuse diabetic macular edema with foveal cystoid changes

Israel Medical Association Journal

Volumn 8, Issue 2, 2006, Pages 83-87

  Barak, Adiel ^a,b   Regenbogen, Michael ^a,b   Goldstein, Michaella ^a,b   Loewenstein, Anat ^a,b  

^a TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Diabetic macular edema; Diabetic retinopathy; Foveal cystoid changes; Triamcinolone acetonide

Indexed keywords

CIPROFLOXACIN; LIDOCAINE; TRIAMCINOLONE ACETONIDE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC MACULAR EDEMA; DRUG DOSE REGIMEN; FEMALE; HEALTH CARE FACILITY; HEALTH CARE MANAGEMENT; HEALTH CARE ORGANIZATION; HUMAN; INTRAOCULAR PRESSURE; MALE; OPHTHALMOLOGY; OUTCOME ASSESSMENT; RETINA FOVEA; RETINA MACULA CYSTOID EDEMA; TERTIARY HEALTH CARE; UNIVERSITY; VISUAL ACUITY; VISUAL DISORDER;

AGED; ANTI-INFLAMMATORY AGENTS; DIABETIC RETINOPATHY; FEMALE; FOVEA CENTRALIS; GLUCOCORTICOIDS; HUMANS; INJECTIONS; MACULAR EDEMA, CYSTOID; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; TREATMENT OUTCOME; TRIAMCINOLONE ACETONIDE; VISUAL ACUITY; VITREOUS BODY;

EID: 33244477448     PISSN: 15651088     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Klein R., Moss SE. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. IV: Diabetic macular edema. Ophthalmology 1984;91: 1464-74.
2. Photocoagulation for diabetic macular edema, Early Treatment Diabetic Retinopathy Study report number 1. Early Treatment Diabetic Retinopathy Study research group. Arch Ophthalmol 1985; 103:1796-806.
3. Abe T, Hayasaka S, Nagaki Y, Kadoi C, Matsumoto M, Hayasaka Y. Pseudophakic cystoid macular edema treated with highdose intravenous methylprecinisolone. J Cataract Refract Surg 1999;25:1286-8.
4. Antcliff RJ, Spalton DJ, Stanford MR, Graham EM, Ffytche TJ, Marshall J. Intravitreal triamcinolone for uveitic cystoid macular edema: an optical coherence tomography study. Ophthalmology 2001; 108:765-72.
5. Heier JS, Topping TM, Baumann W, Dirks MS, Chem S. Ketorolac versus prednisolone versus combination therapy in the treatment of acute pseudophakic cystoid macular edema. Ophthalmology 2000;107:2034-8; discussion 2039.
6. Jampol LM. Pharmacologic therapy of aphakic and pseudophakic cystoid macular edema. 1985 update. Ophthalmology 1985;92:807-10.
7. Karacorlu M, Ozdemir H, Karacorlu S. Intravitreal triamcinolone acetonide for the treatment of chronic pseudophakic cystoid macular oedema. Acta Ophthalmol Scand 2003;81:648-52.
8. Nelson ML, Martidis A. Managing cystoid macular edema after cataract surgery. Curr Opin Ophthalmol 2003;14:39-43.
9. Yoshikawa K, Kotake S, Ichiishi A, Sasamoto Y, Kosaka S, Matsuda H. Posterior sub-Tenon injections of repository corticosteroids in uveitis patients with cystoid macular edema. Jpn J Ophthalmol 1995;39:71-6.
10. Wilson CA, Berkowitz BA, Sato Y, Ando N, Handa JT, de Juan E Jr. Treatment with intravitreal steroid reduces blood-retinal barrier breakdown due to retinal photocoagulation. Arch Ophthalmol 1992; 110: 1155-9.
11. Ando N, Sen HA, Berkowitz BA, Wilson CA, de Juan E Jr. Localization and quantitation of blood-retinal barrier breakdown in experimental proliferative vitreoretinopathy. Arch Ophthalmol 1994; 112:117-22,
12. McCuen BW 2nd, Bessler M, Tano Y, Chandler D, Machemer R. The lack of toxicity of intravitreally administered triamcinolone acetonide. Am J Ophthalmol 1981;91:785-8.
13. Challa JK, Gillies MC, Penfold PL, Gyory JF, Hunyor AB, Billson FA. Exudative macular degeneration and intravitreal triamcinolone: 18 month follow up. Aust N Z J Ophthalmol 1998;26:277-81.
14. Danis RP. Ciulla TA, Pratt LM, Anliker W. Intravitreal triamcinolone acetonide in exudative age-related macular degeneration. Retina 2000;20:244-50.
15. Jonas JB, Degenring R. Intravitreal injection of crystalline triamcinolone acetonide in the treatment of diffuse diabetic macular oedema. Klin Monatsbl Augenheilkd 2002;219:429-32.
16. Jonas JB, Kreissig I, Degenring R. Intraocular pressure after intravitreal injection of triamcinolone acetonide. Br J Ophthalmol 2003;87:24-7.
17. Martidis A, Duker JS, Greenberg PB, et at. Intravitreal triamcinolone for refractory diabetic macular edema. Ophthalmology 2002; 109:920-7.
18. Jonas JB, Solker A. Intraocular injection of crystalline cortisone as adjunctive treatment of diabetic macular edema. Am J Ophthalmol 2001; 132:425-7.
19. Fong DS, Segal PP, Myers F, Ferris FL, Hubbard LD, Davis MD, Subretinal fibrosis in diabetic macular edema. ETDRS report 23. Early Treatment Diabetic Retinopathy Study Research Group. Arch Ophthalmol 1997;115:873-7.
20. Jonas JB, Kreissig I, Hugger P, Sauder G, Panda-Jonas S, Degenring R. Intravitreal triamcinolone acetonide for exudative age related macular degeneration. Br J Ophthalmol 2003;87:462-8.
21. Jonas JB, Sofker A, Degenring R. Intravitreal triamcinolone acetonide as an additional tool in pars plana vitrectomy for proliferative diabetic retinopathy. Eur J Ophthalmol 2003;13:468-73.
22. Jonas JB, Kreissig I, Degenring RF. Intravitreal triamcinolone acetonide as treatment of ischemic ophthalmopathy. Eur J Ophthalmol 2003; 13:575-6.
23. Jonas JB, Kreissig I, Degenring RF. Neovascular glaucoma treated by intravitreal triamcinolone acetonide. Acta Ophthalmol Scand 2003;81:540-1.
24. Jonas JB, Sofker A, Hayler J, Degenring RF. Intravitreal crystalline triamcinolone acetonide as an additional tool in pars plana vitrectomy for complicated proliferative vitreoretinopathy? Acta Ophthalmol Scand 2003;81:663-5.
25. Jonas JB, Kreissig I, Sofker A, Degenring RF. Intravitreal injection of triamcinolone for diffuse diabetic macular edema. Arch Ophthalmol 2003;121:57-61.